Eimeria tenella Elongation Factor-1 alpha (EF-1 alpha) Coadministered with Chicken IL-7 (chIL-7) DNA Vaccine Emulsified in Montanide Gel 01 Adjuvant Enhanced the Immune Response to E. acervulina Infection in Broiler Chickens

摘要

The current study was undertaken to assess the vaccine efficacy of Eimeria tenella EF-1 alpha/chicken IL-7 (chIL-7) DNA vaccine when administered with Montanide Gel 01 adjuvant against live Eimeria acervulina challenge in commercial broiler chickens. The criteria used for the evaluation of vaccine efficacy were weight gain, duodenal lesion scores, oocyst counts, humoral antibody response, and duodenal proinflammatory cytokine gene expression. Chickens vaccinated with EF-1 alpha (100 mu g)/chIL-7 (20 mu g) in Gel 01 PR adjuvant showed body weight gain similar to the uninfected control and higher oocyst shedding, a lower gut lesion score, and higher proinflammatory cytokine gene expression than did the infected controls. Moreover, chickens vaccinated with chIL-7 (20 mu g) in Gel 01 PR adjuvant shed fewer oocysts with reduced gut lesion scores and produced higher levels of antiEF-1 alpha serum antibody than did the infected control. Chickens vaccinated with EF-1 alpha (50 mu g)/chIL-7 (20 mu g) in Gel 01 PR adjuvant showed higher weight gains than did the infected control and shed significantly fewer oocysts than the infected control. Furthermore, chickens vaccinated with EF-1 alpha (100 mu g) in Gel 01 PR adjuvant demonstrated the lowest anti-EF-1 alpha serum antibody levels. This study demonstrated the beneficial effects of using EF-1 alpha and/or host cytokine chIL-7 DNA vaccine together with Gel 01 PR adjuvant to improve T-cell-mediated effector function in broiler chickens challenged with live E. acervulina.